| CELG Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CELG market cap history going back to 2/11/2010:
Also see: CELG Shares Outstanding History and CELG YTD Return |
CELG Market Cap History — Celgene Capitalization Over Time
As of 10/29/2019 Celgene has a market cap of 75.66 billion. Investors often follow the CELG market cap history to compare the size of the company over time.
This page shows CELG market capitalization trends over time, with 41 market cap datapoints presented, dating back to 2/11/2010.
| CELG Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELG Historical Market Cap: +11.50% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CELG Stock Price Chart |
| About Bristol Myers Squibb Co. |
| Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. We show 41 historical shares outstanding datapoints in our CELG shares outstanding history coverage, used to compute CELG market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CELG market cap history over the course of time is important for investors interested in comparing CELG's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CELG versus a peer is one thing; comparing CELG market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CELG can fluctuate over the course of history. With this page we aim to empower investors researching CELG by allowing them to research the CELG market cap history. |
| CELG Current Stock Quote |
Quotes delayed 20 minutes  Free CELG Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CELG Share Performance |
| Market Cap Peers |
| Celgene (CELG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CELL Market Cap History CELU Market Cap History CELZ Market Cap History CEMI Market Cap History CERC Market Cap History CERE Market Cap History CERS Market Cap History CFMS Market Cap History CFRX Market Cap History CGEM Market Cap History More Healthcare companies » |
CELG Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
